Physician
Vladimir Zelenko M.D. P.C.
Vladimir Zelenko M.D. P.C. was paid $10.95M by Medicaid between Jan 2018 and Nov 2024, across 85 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.
33Billing provider infoVLADIMIR ZELENKO M.D. P.C.
MONROE, NY 10950
MONROE, NY 10950
33aNPI1063669562assigned 08/26/2008
33bProvider typeFamily Medicine Physician
28Total paid$10.95M
24GClaims178,289
24DCodes billed85
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#13 of 2,605
Median peer was paid$10K
This provider vs. median1,085×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,874 | $506K | |
| 2019 | 18,759 | $998K | |
| 2020 | 24,221 | $1.40M | |
| 2021 | 37,091 | $2.41M | |
| 2022 | 33,688 | $2.31M | |
| 2023 | 21,407 | $1.45M | |
| 2024incomplete | 35,249 | $1.87M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 53,249 | 44,599 | $4.64M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 23,126 | 20,531 | $2.96M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.1% | 6,448 | 6,442 | $667K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.7% | 4,321 | 4,314 | $512K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 1,879 | 1,876 | $293K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.5% | 2,127 | 2,126 | $271K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 1,451 | 1,448 | $174K |
| 99051 | 1.5% | 26,182 | 24,244 | $166K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 1,199 | 1,172 | $133K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 2,184 | 2,099 | $116K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 918 | 918 | $109K |
| 99385 | <1% | 855 | 855 | $107K |
73 more codes
| 69210 | <1% | 1,789 | $97K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 3,278 | $82K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,814 | $81K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 23,367 | $76K |
| 17110 | <1% | 453 | $59K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 298 | $33K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 213 | $28K |
| 99381 | <1% | 219 | $26K | |
| 92587 | <1% | 806 | $24K | |
| 99383 | <1% | 172 | $23K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,240 | $21K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,527 | $20K |
| 99442 | <1% | 215 | $20K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 260 | $18K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 89 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 245 | $14K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 131 | $14K |
| 76857 | <1% | 334 | $14K | |
| 99382 | <1% | 87 | $11K | |
| 99443 | <1% | 77 | $10K | |
| 99441 | <1% | 202 | $10K | |
| 90756 | <1% | 377 | $9K | |
| M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | <1% | 13 | $9K |
| 30210 | <1% | 43 | $8K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 88 | $7K |
| 87081 | <1% | 1,541 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 78 | $6K |
| 87428 | <1% | 101 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 203 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 245 | $5K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 12 | $4K |
| 90688 | <1% | 225 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 666 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 135 | $3K |
| 81000 | <1% | 1,000 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,048 | $3K |
| 92550 | <1% | 254 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 55 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 62 | $2K |
| 99050 | <1% | 229 | $2K | |
| 85048 | <1% | 571 | $1K | |
| 90686 | <1% | 362 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 55 | $1K |
| 90658 | <1% | 60 | $1K | |
| 96127 | <1% | 135 | $801.54 | |
| 73630 | <1% | 28 | $613.72 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 283 | $516.57 |
| 73130 | <1% | 24 | $497.86 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 180 | $470.94 |
| 93000 | <1% | 37 | $444.00 | |
| 81003 | <1% | 301 | $430.16 | |
| 73110 | <1% | 14 | $380.10 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 47 | $324.76 |
| 90710 | <1% | 224 | $299.42 | |
| 81001 | <1% | 109 | $260.48 | |
| 90697 | <1% | 289 | $158.54 | |
| 92567 | <1% | 14 | $152.74 | |
| 86580 | <1% | 26 | $104.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 876 | $52.72 |
| 85018 | <1% | 29 | $44.80 | |
| 90744 | <1% | 56 | $28.59 | |
| 90723 | 0% | 396 | $0.00 | |
| 90698 | 0% | 126 | $0.00 | |
| 90647 | 0% | 47 | $0.00 | |
| 90716 | 0% | 13 | $0.00 | |
| 90696 | 0% | 98 | $0.00 | |
| 90670 | 0% | 566 | $0.00 | |
| 90648 | 0% | 36 | $0.00 | |
| 90461 | 0% | 35 | $0.00 | |
| 90700 | 0% | 43 | $0.00 | |
| 90715 | 0% | 26 | $0.00 | |
| 90734 | 0% | 41 | $0.00 | |
| 90713 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAMSS, JONATHAN (MD)
| Provider | Location | Paid |
|---|---|---|
| Levelup MD Urgent Care NJ LLC | Emerson, NJ | $261K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.